| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a novel skin fibrosis inhibitor which can effectively inhibit the fibrosis of skin. <P>SOLUTION: This problem is solved by using the skin fibrosis inhibitor which contains, as effective components, a compound having a histone deacetylate enzyme inhibiting function and/or its salt which is permitted in terms of chemicals, and a polyunsaturated fatty acid and/or its salt which is permitted in terms of chemicals. Furthermore, the skin fibrosis inhibitor can be used for the medical treatment of skin diseases such as cheloid, pterygium, hypertrophic scar or the like and/or the prevention of these diseases. <P>COPYRIGHT: (C)2013,JPO&INPIT |
